BACKGROUND: Critical to the continual improvement of cryoablation efficacy is deciphering the biochemical responses of cells to low-temperature exposure. The identification of delayed-onset cell death has allowed for the manipulation of cellular responses through the regulation of apoptosis. We hypothesized that in addition to delayed apoptotic events associated with mild subfreezing temperatures (10 to À 25 1C), cells exposed to ultra-low temperatures (o À 30 1C) may undergo rapid, early-onset apoptosis. METHODS: Human prostate cancer model and cells (PC-3) were exposed to temperatures of À 60, À 30 and À 15 1C to simulate a cryoablative procedure. Using a combination of flow-cytometry, fluorescent microscopy and western blot analyses, samples were assessed at various times post thaw to identify the presence, levels and the pathways involved in cell death. RESULTS: Exposure to temperatures o À 30 1C yielded a significant apoptotic population within 30 min of thawing, peaking at 90 min (B40%), and by 6 h, only necrosis was observed. In samples only reaching temperatures 4 À 30 1C, apoptosis was not noted until 6-24 h post thaw, with the levels of apoptosis reaching B10% ( À 15 1C) and B25% ( À 30 1C) at 6 h post thaw. Further, it was found that early-onset apoptosis progressed through a membrane-mediated mechanism, whereas delayed apoptosis progressed through a mitochondrial path.
INTRODUCTION
Cryosurgical ablation of prostate cancer is a treatment modality that has demonstrated steady growth over the past 10 years. This trend has been reinforced by the publication of the first long-term follow-up study, showing comparative results between cryosurgery and more traditional treatments 1 and the Best Practice guidelines for prostate cryosurgery issued by the American Urological Association. 2 Although clinical application continues to grow, there remains a void in our understanding of the specific molecular-based responses of cancer cells following lowtemperature insults. This deficit, if not addressed, will likely hinder further improvements in treatment efficacy.
During a cryosurgical procedure, cells nearest to the cryoprobe (o À 60 1C) are believed to predominantly die via rupture caused by the physical stresses of intra/extracellular ice formation. Extending peripherally, as cooling rates decrease and temperatures remain more elevated, mechanical destruction gradually gives way to biologically driven cell death. In this outer region (4 À 40 1C), cells undergo a combination of lessening physical rupture and increasing levels of necrotic and apoptotic cell death. 3, 4 It is also in this region where incomplete tissue ablation can occur, although some cancer cells can survive even at temperatures o À 40 1C. 5 Given the incomplete initial destruction and the occurrence of cell-mediated death, it is the cryolesion periphery that has emerged as the primary focus of cellular/ molecular research following freezing.
In 1998, Hollister et al. 6 identified the presence of apoptosis following freezing. Since then, apoptosis, or programmed cell death, has been shown to be a major contributor to cell death following cryosurgery. [7] [8] [9] [10] Occurring over a period of hours to days post thaw, apoptosis is typically associated with the freeze zone periphery and is largely modulated by the caspase family of proteases 11 and the two distinct paths of caspase-dependent apoptosis, intrinsic and extrinsic. The intrinsic, or mitochondrialmediated, pathway is characterized by the 'opening' of the mitochondrial permeability transition pore, [12] [13] [14] release of cytochrome-c 15, 16 and activation of caspase-9. 17, 18 The intrinsic pathway has been shown to be the predominant form of cryoinduced delayed-onset cell death. 19 The second caspasedependent pathway is the extrinsic, or membrane-mediated, pathway. Induced by death receptor ligands, 20, 21 loss of growth factor signaling 22, 23 or alterations in cell attachment signaling, the extrinsic pathway progresses through caspase-8. The role of membrane-modulated cell death following cryosurgery, while reported, is less understood. Recently, early-onset programmed cell death occurring within hours post thaw was observed in cells exposed to temperatures o À 20 1C. 25 These observations prompted further investigation into the role of early-onset apoptosis in cell death following cryoablation. As such, in vitro and an engineered prostate tumor model 25 were employed to characterize this rapid apoptotic death to determine the mechanisms involved in this response. If the molecular pathways underpinning rapid apoptotic death differ from those in delayed-onset apoptosis, then novel targets for cryoadjuvants maybe identified.
MATERIALS AND METHODS

Cell and three-dimensional (3D) cultures
The human prostate cancer cell line (PC-3) was obtained from the ATCC (Rockville, MD, USA). The PC-3 mutant cell line variants PBcl-2 (overexpressing Bcl-2) and PBcl-2n (low levels of Bcl-2) 26, 27 were obtained from Dr Kyprianou (University of Kentucky). Cultures were maintained at 37 1C, 5% CO 2 :95% air in RPMI-1640 culture medium (Caisson Laboratories, Logan City, UT, USA) fortified with 10% fetal bovine serum (Atlanta Biologics, Atlanta, GA, USA) and 1% penicillin/streptomycin (Mediatech, Herndon, VA, USA). Cells were cultured in 75 cm 2 t-flasks with media replenishment every 3 days. Subcultures were prepared 24 h before freezing in Costar 96-well strip well plates at 2.5 Â 10 4 cells per well or in 100-mm petri dishes at 7.5 Â 10 5 cells per dish. For engineered prostate models, rat tail type I collagen solution (BD Bioscience, Bedford, MA, USA) was used to form 0.2% w/v gel matrices as per the manufacturer's directions. Cells, 2.5 Â 10 6 cells per ml, were suspended in the collagen solution before solidification in 35-mm petri dishes. The matrices were cultured 7 days before freezing and media replenished daily. All experiments were performed on cells between passages 3 and 20.
Freezing protocol
One hour before freezing 100 ml media per well or 1 ml media per dish was replenished with and without the addition of 500 nM of TRAIL (Biomol International, Plymouth Meeting, PA), 1 mM docetaxel (LC Laboratories, Woburn, MA, USA) or 10 mM of the pan-caspase inhibitor z-VAD-fmk (EMD, San Diego, CA, USA). Samples were then placed into aluminum-freezing blocks partially submerged in a circulating, temperature-controlled bath at À 15 or À 30 1C for 15 min with ice nucleation at 120 s (sample temperature À 3±2 1C) to prevent supercooling. Following freezing, samples were passively thawed at room temperature before returning to 37 1C for culture and post-thaw assessment.
Cell viability
Sample cell-viability assessment was performed using the alamarBlue (Invitrogen, Carlsbad, CA, USA) metabolic activity assay. At 0.5, 1.5, 3, 6 and 24 h post thaw, culture medium was decanted and 100 ml per well or 1 ml per dish of the working alamarBlue solution was added. Samples were incubated in the dark at 37 1C for 30 min (±1 min). Fluorescence was evaluated using a Tecan SPECTRAFluorPlus plate reader (Tecan Austria) with a 530-nm excitation/590-nm emission filter set.
Cell-death analysis
Samples were assessed for the presence of apoptotic, necrotic and live cells using the Vybrant Apoptosis assay (Molecular Probes, Eugene, OR, USA). Fluorescent staining was visualized using a Zeiss Axiovert 200 fluorescent microscope with the AxioVision 4 software (Carl Zeiss, Oberkochen, Germany). All images were taken with a Â 10 objective. Quantitative analysis was performed using automated analysis feature in the AxioVision software as well as manual counts.
Flow-cytometric analysis
Levels of apoptosis were quantified using microfluidic flow cytometry. At 0.5, 1.5, 3, 6 and 24 h post thaw, samples were stained cells using the Vybrant Apoptosis assay for 20 min. Samples were then analyzed to quantitative populations of unlabeled (live), necrotic (propidium iodide (PI) positive) and apoptotic (YoPro1 positive) using the Guava PCA-96 system with the CytoSoft 5.2 software (Millipore, Billerica, MA, USA).
Protein analysis
Protein isolation: Samples frozen in dishes were collected at 0.5, 1.5, 3, 6 and 24 h post thaw. Samples were lysed by vortexing in 25-100 ml of modified RIPA buffer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 100 mM Tris-HCL pH 7.6, 150 mM NaCl, 5 mM EDTA, 1 mM phenylmethanesulfonyl fluoride, 1 mg ml À 1 leupeptin, 1 mM sodium fluoride and 1 mM sodium vanadate) followed by 15 min of centrifugation (16000 g) at 4 1C. The supernatant containing cellular proteins was collected and stored at À 80 1C until analyzed.
Protein quantification: Protein extracts were quantified by bicinchoninc acid protein assay according to the manufacturer's protocol (Pierce, Rockford, IL, USA).
Western blot analysis: Protein samples (30 mg) were aliquoted into 0.5 ml tubes, and the total volume was adjusted with RIPA buffer. An equal amount of 5 Â loading buffer (0.06 M Tris pH 6.8, 2% SDS, 10% glycerol and 0.025% bromophenol blue) was then added, and samples were then heated to 95 1C for 5 min. Samples were separated on an SDSpolyacrylamide gel (100 V) and then transferred to polyvinylidene difluoride membranes by semidry transfer electrophoretic transfer (Transblot SD Semi-Dry Transfer Cell; Bio-Rad, Hercules, CA, USA). Membranes were blocked using 5% bovine serum albumin (Life Technologies, Gaithersburg, MD, USA) in 1% Tris-buffered saline with Tween-20 (10 mM Tris pH 7.6, 150 mM NaCl and 0.05% Tween À 20) for 2 h at room temperature and were then incubated with primary antibodies at 4 1C overnight and secondary antibodies for 1 h at room temperature. bTubulin, poly ADP ribose polymerase (PARP) and Caspase-3, -8 and À -9 were obtained from Cell Signaling Technologies (Danvers, MA, USA). Blots were visualized by chemiluminescent detection (Cell Signaling Technologies) using a Fujifilm LAS-3000 Image Reader (Stamford, CT, USA)
Data analysis
Flow-cytometry counts and fluorescence units were converted to percent based on normothermic controls (37 1C). Cytometry and viability experiments were repeated for a minimum of three times with an intraexperiment repeat of X6 samples per experiment. Western blot experiments were repeated on a minimum of three separate experimental repeats and protein isolations.
RESULTS
Identification and quantification of rapid-onset apoptosis
The presence of delayed-onset apoptotic cell death following mild freezing insults (4 À 30 1C) has been well characterized. Recently, early-onset cell death occurring within hours post thaw was observed following more severe freezing insults (o À 30 1C). 25 To determine the extent of early-onset cell death, we utilized both the in vitro and tissue-engineered systems. Human prostate cancer cells (PC-3) were cultured to confluent monolayers and frozen to À 15 or À 30 1C with and without the pan-caspase inhibitor z-VAD-fmk. At 1.5, 3, and 6 h post thaw, cells were stained with Hoechst, PI and YoPro1, indicating living, necrotic and apoptotic cells, respectively, and visualized using fluorescence microscopy ( Figure 1 ). Quantitative analysis of the fluorescent micrographs to determine the percentage of each of the subpopulations is presented in Table 1 . Sample analysis revealed a peak in apoptotic activity at 6-24 h post thaw following freezing to À 15 1C, whereas at À 30 1C, apoptosis was found to peak at 0.5-1.5 h post thaw. The appearance of apoptotic populations within the first 1.5 h of recovery, following a severe freezing insult ( À 30 1C) in the in vitro culture, were consistent with previous studies employing a 3D prostate model (data not shown). Analysis of the overall contribution of apoptotic cell death was conducted though caspase-inhibitor studies. The addition of a pan-caspase inhibitor yielded a notable reduction in apoptosis following exposure to À 15 and À 30 1C at all times investigated (Figure 1 ), suggesting that, similar to delayed-onset cell death, rapid-onset death progressed through a caspase-mediated pathway.
The involvement of early-onset apoptosis was corroborated via flow-cytometric analysis employing both in vitro (two-dimensional (2D)) and tissue-engineered models (3D) ( Figure 2 ). As was Figure 1 . Mechanisms of cell death following mild and severe freezing insults with and without caspase inhibition or membrane-mediated apoptotic induction. Cell cultures were frozen for 15 min to either À 15 or À 30 1C with and without 10 mM of the pan-caspase inhibitor z-VADfmk or 500 nM solubilized TRAIL. At 1.5, 3 and 6 h post thaw, cultures were stained with Hoechst (blue, live cells), PI (red, necrotic/freeze rupture cells) and Yo-Pro 1 (green, apoptotic cells) and visualized using a fluorescence microscope with a Â 50 magnification. Abbreviation: Ctrl, control. Cells were labeled at 1.5, 3 and 6 h postfreeze, visualized via fluorescent microscopy (images presented in Figure 1 ), and fluorescence histogram analysis was conducted using the Ziess AxioVision imaging software. Data were collected from three separate fields and are expressed as percentages of the population.
observed in the fluorescent microscopy analysis, apoptotic cell death was found to peak at 6-24 h post thaw following mild freezing ( À 15 1C) in both model systems (2D: 24% at 24 h and 3D: 19% at 24 h). Following exposure to lower temperatures ( À 30 1C), apoptosis was found to peak at 0.5-1.5 h post thaw (2D: 30% at 1.5 h and 3D: 25% at 1.5 h). These data further corroborated rapid activation of apoptotic cell death occurring within the first 1.5 h following exposure to ultra-low temperatures (o À 30 1C). This phenomenon was found to be consistent across both traditional monolayer cultures (2D) and in an engineered prostate tumor model (3D).
With the identification of the rapid activation of apoptosis following a severe freeze insult, investigations into the molecular mechanism of progression were conducted. Accordingly, samples in both 2D and 3D models were frozen to À 15 or À 30 1C, and total protein was extracted temporally over the initial 24 h of recovery. Sample protein extracts were then analyzed to determine the extent of apoptotic progression via western blotting for the hallmark executioner phase apoptotic proteins caspase-3 and PARP cleavage. Western blot analyses revealed a delayed reduction in pro-caspase-3 and PARP protein levels, indicative of protein cleavage (downstream apoptotic events), in samples frozen to À 15 1C (Figures 3a and b) . Monolayer and 3D matrices alike showed reduced levels of pro-caspase-3 and PARP 1.5-3 h post thaw, with levels decreasing throughout the 24-h recovery period. These data indicate an increase and progression in apoptotic cell death during an extended recovery/response interval. In samples exposed to À 30 1C, however, cleavage of procaspase-3 and PARP was observed within 0.5 h post thaw in both models. Although more rapid in activation timing postfreeze, as with warmer temperatures, the level of these proteins were also found to decrease over the entire assessment period. Data obtained in the western blot studies confirmed the involvement of molecular-based apoptotic signaling, resulting in earlier onset of programmed cell death following exposure to extreme freezing insults. These data in combination with the fluorescence micrographs and the flow-cytometry data indicated that the early-onset death was both apoptotic in nature and observed independent of the experimental model (2D vs 3D) employed.
Investigation of the apoptotic initiation pathways
With the identification of a molecular basis behind the early-onset cell death, analysis of caspase-8 and -9 protein levels were conducted in an attempt to determine what apoptotic induction pathway (intrinsic vs extrinsic) was responsible for early-onset apoptosis (Figures 3a and b) . Caspase-9 is integral to the intrinsic apoptotic pathway activated following cytochrome-c release from the mitochondria and autolysis of the apoptosome, whereas the extrinsic pathway progresses through caspase-8, which is activated by the formation of the death-inducing signaling complex. Western blot analysis of caspase-9 revealed that exposure to both mild ( À 15 1C) and severe ( À 30 1C) freezing resulted in cleavage of pro-caspase-9 (activation) by 1.5 h postfreeze in monolayer samples and at 3 h in the 3D model. These data revealed that caspase-9 cleavage appeared in a delayed time frame and therefore could not account for the observed rapid-onset apoptosis following exposure to ultra-low temperatures that appeared within the first 1 h of recovery at À 30 1C.
As temporal western blot analysis of caspase-9 activation did not comport with the timing of early-onset apoptosis, studies were expanded to investigate possible caspase-8 involvement. Western blot analysis of pro-caspase-8 revealed no cleavage at any time during the recovery period following freezing to À 15 1C in either model systems. Interestingly, in samples frozen to À 30 1C, caspase-8 activation (pro-caspase-8 cleavage) was found to occur within 0.5 h postfreeze and peaked at 1.5 h post thaw in both the monolayer and tissue-engineered models. The timing of caspase-8 activation was found to correlate with the appearance of early-onset apoptotic populations, suggesting that the extrinsic, or membrane-induced, apoptotic pathway was activated as a result of exposure to ultra-low temperatures and responsible for the rapid activation and progression of early-onset apoptosis.
Induction and modulation of early-onset apoptosis With the presence of early-onset apoptosis identified following exposure to lower temperatures (o À 30 1C) and molecular analyses, indicating progression via a caspase-8-mediated mechanism, the effect of inducing extrinsic pathway activation during freezing was investigated. To this end, solubilized TRAIL, a known initiator of membrane-mediated apoptosis, was added to samples before freezing, and the extent of apoptosis postfreeze was assessed via fluorescence microscopy ( Figure 1 , À 15 1C þ TRAIL). The addition of TRAIL to nonfrozen control sample was found to have little effect, yielding only a slight increase in the levels of apoptosis observed. When samples were treated with TRAIL followed by freezing to À 15 1C, an initial peak in apoptosis was observed at 1.5 h post thaw followed by a second, delayed peak at 6-24 h post thaw. Interestingly, the initial peak in apoptosis at 1.5 h postfreeze in the À 15 1C/TRAIL samples was similar to that observed in samples frozen to À 30 1C. The delayed peak in the 6-24 h postfreeze time frame was similar to that seen in the non-TRAIL-treated À 15 1C samples. Accordingly, the addition of TRAIL to samples before À 15 1C freezing resulted in a hybrid pattern of apoptotic induction, combining both response profiles seen at À 15 and À 30 1C and yielding an overall increase in total cell death following À 15 1C freezing (97% À 15 1C/TRAIL vs 42% À 15 1C only, Figure 5 ). Assessment of the activation of caspases-8 and -9 (pro-caspase-8 and 9 cleavage) in samples frozen to À 15 1C with TRAIL, once again revealed a hybrid cleavage pattern more similar to samples frozen to À 30 1C than that of À 15 1C freeze-only samples (Figure 4 ). Pro-caspase-9 cleavage was delayed, not appearing until 1.5-3 h post thaw, which was consistent with samples frozen to À 15 1C without TRAIL. Although consistent with À 15 1C freeze-only samples, the pro-caspase-9 cleavage pattern appeared well after the detection of apoptotic populations via fluorescent microscopy ( Figure 1) . Analysis of pro-caspase-8 cleavage in the À 15 1C/ TRAIL samples revealed pro-caspase-8 cleavage occurring within 0.5 h postfreeze. This cleavage activation pattern of (Figure 5 ). To further examine the impact of the freeze/TRAIL treatment, studies utilizing the PBcl-2 and Bcl-2n variants were conducted. In addition, the treatment of cells with low dose (subclinical) docetaxel were also conducted for comparative purposes. These studies revealed that exposure of each of the cell types to either TRAIL or Tax alone resulted in minimal (p10 ± 7%) cell death, whereas exposure to À 20 1C resulted in B50% cell death in each cell type ( Figure 6 ). Exposure to the combination of À 20 1C/Tax yielded a further increase in cell death to B75%, whereas the combination treatment of À 20 1C/TRAIL yielded even greater cell death in all three of the prostate cancer cell lines examined. Compared with freezing or Tax/freezing, the combination treatment of TRAIL/freezing resulted in near-complete cell destruction (X95%) of the PBcl-2 cells, which was similar to the results from the PC-3 and PBcl-2n samples (7% vs 3% vs 5% survival, respectively) ( Figure 6 ).
DISCUSSION
In this study, we employed two distinct models, monolayer cultures and a tissue-engineered human prostate cancer model, to investigate the apoptotic pathways activated within a cryolesion. Cancer cells can be highly plastic, and their phenotypes altered by the extracellular environment and cell-cell communication. 28, 29 By employing 3D cultures, such as those obtained using the tissue engineered model of the prostate, a more in vivo-like environment is achieved in turn yielding more in vivo-like cellular responses. [30] [31] [32] During cryosurgery, the freeze zone formed around the cryoprobes creates a highly dynamic environment composed of gradients in ice composition, osmolarity, pH and temperature. Each of these variables contributes a level of stress to the targeted cells that changes over the duration of the freeze episode and as a result of the distance from the cryoprobe. By utilizing a 3D culture, many of the variables associated with a cryolesion are maintained, whereas use of in vitro monolayer cultures allows for targeted analysis at specific temperatures. Through the utilization of the 3D tissue engineered model of the prostate, model, we were able to determine that apoptotic cell death was not limited to delayed time frames at the warmer isotherms following freezing, rather a significant apoptotic population was found to appear as early as 1 h post thaw at temperatures as low as À 60 1C. Following this initial appearance of apoptosis at ultra-low temperatures, a wave of apoptotic cell death was observed radiating out from the center of the cryogenic lesion as postfreeze recovery progressed in tissue engineered model of the prostate samples. These data suggest that the extent, timing and manifestation of cryosurgical-induced apoptosis is directly related to the level of stress cells exposed to during the freeze and recovery period. The data in this study suggest that the activation and progression of apoptotic events happens rapidly in the core of a cryogenic lesion (o À 30 1C) but occurs in a more delayed manner at temperatures associated with the lesion periphery (4 À 30 1C normally).
To ensure these effects were not an artifact associated with the tissue engineered model of the prostate 3D model, the timing and mechanism of cell death were also investigated utilizing traditional in vitro monolayer cultures. In these studies, similar cellular behavior was observed following targeted freezing to À 15 and À 30 1C, illustrating that the phenomenon of early-onset apoptosis following ultra-low-temperature exposure was not unique to the Tissue Engineered Model of the Prostate model but consistent across experimental models.
Early-onset apoptotic cell death was found in samples frozen to temperatures at p À 30 1C and was absent in samples frozen at warmer temperatures. The addition of a pan-caspase inhibitor yielded significant decreases in the extent of apoptosis at all temperatures and times examined. This suggests that, as previously reported, delayed apoptotic cell death associated with warmer subfreezing temperatures in the periphery of a cryogenic lesion. Likewise, early-onset apoptosis at colder temperatures progressed through the caspase-dependent pathways. Molecular analyses of downstream apoptotic events including fluorescence microscopy and western blot analysis of cleavage of pro-caspase-3 to active caspase-3 and PARP cleavage further support the premise that early-onset cell death is apoptotic in nature.
With the identification of early-onset apoptosis at temperatures o À 30 1C, targeted analysis aimed at identifying the pathway responsible for apoptotic progression at these ultra-cold temperatures was conducted. Analysis of samples frozen to À 30 1C revealed cell-death progression through the extrinsic membranemediated pathways via caspase-8. This was found to be in contrast to that seen at warmer freezing temperatures such as À 15 and À 20 1C where apoptotic activation and progression was found to be primarily through an intrinsic mitochondrial path. Although not previously reported following freezing, the rapid induction of caspase-8-mediated cell death has been characterized following other cellular insults such as ionizing radiation. 33, 34 Although the upstream activator(s) of caspase- 8 have not yet been identified, and was beyond the scope of this study, a number of potential mechanisms may exist. Cells exposed to ultralow temperatures (that is, close to a cryoprobe) experience more rapid cooling rates than those at warmer temperatures (such as further away from the cryoprobe). The faster rates and lower temperatures yield greater levels of cell rupture either through the formation of intracellular ice or through increased necrotic cell death. These events release intracellular contents into the extracellular environment capable of initiating the extrinsic apoptotic pathway in cells not initially destroyed by freeze rupture. Further, rapid cooling rates result in the formation of ice composed of smaller crystals and with greater shear forces. Such forces have greater impact on the cell-matrix/cell attachments or cause damaging deformations to cell membranes or intracellular structures, both of which have been shown to lead to the activation caspase-8. 35 Interestingly, although caspase inhibition greatly increased post thaw survival at elevated temperatures, it did not improve survival to the same extent at lower temperatures having only a slight, yet, significant effect at temperatures at p À 60 1C (data not shown). The observed protective effect provided by caspase inhibition at ultra-low temperatures (o À 60 1C) was consistent with previous reports by Hollister et al. 6 and Znati et al. 36 The findings of a significant population of rapid-onset apoptotic cells at ultra-low temperature, yet, only a slight level of protection afforded by caspase inhibition, illustrates the complex nature of cell death and the 'cross-talk' that exists between the cell death pathways. For example, following more rapid cooling and lower-temperature exposure, surviving cells are likely stressed to such a degree that even when the apoptotic process is altered using caspase inhibition the cells that survive physical destruction (ice rupture) are unable to recover and ultimately die. In such cases, caspase activation and progression through classical apoptosis maybe the default mechanism of cell death; however, the inability to complete such pathways, either through caspase inhibition (as was the case in this study), lack of ATP, or other conditions, shunts the death pathway to a more necrotic-like death or a caspase-independent, apoptotic-like death. These transitional cells often are characterized as necrotic as their progression through apoptotic events is rapid and thus often overlooked during analysis.
Although the intrinsic pathway apoptotic progression was found in samples frozen to warm temperatures, whereas the extrinsic pathway was more active at lower temperatures, when cells were frozen at slower cooling rates to warmer temperatures in the presence of solubilized TRAIL (a known initiator of the extrinsic apoptotic pathway) at non-lethal concentrations, postfreeze cell survival and protein signaling mirrored the response seen in samples frozen to lower temperatures (for example, À 30 1C). For instance, in both the À 15 1C/ TRAIL and À 30 1C samples, a rapid activation of caspase-8 (within 0.5 h) followed by the delayed activation of caspase-9 (after 6-24 h) was observed. The near-total destruction of cells frozen to À 15 and À 20 1C in the presence TRAIL illustrates the potential of cell sensitization to membrane-mediated apoptotic pathway activation could have on post-cryosurgical outcome.
Given the heterogeneity of prostate cancer in vivo, a series of phased apoptotic induction studies were conducted using Figure 6 . Impact of combined exposure of TRAIL or Docetaxol and freezing on prostate cancer cell survival. PC-3, PBcl-2 and PBcl-2n samples were frozen to À 20 1C alone and in combination with TRAIL or docetaxol pretreatment. Cell survival was assessed 24 h following freezing and compared with nonfrozen controls.
additional androgen-insensitive prostate cancer cell variants, PBcl2n and PBcl-2. The PBcl-2 and PBcl-2n cell lines are two distinct androgen-insensitive prostate cancer variants characterized by deletion of PTEN, deletion of P53 and normal (PBcl-2n) and upregulated (PBcl-2) levels of Bcl-2 protein (antiapoptotic) expression. 26, 27, 37 These studies were conducted to examine if the observed hybrid (phased) apoptotic activation observed in the Freeze/TRAIL studies was cell type specific or applied to a range of prostate cancer molecular variants. In addition to TRAIL, the combination of Docetaxel (Tax) and freezing was also included to compare hybrid apoptotic path activation (mild Freeze/TRAIL) and that of apoptotic amplification (mild freeze/Tax). Docetaxel is a microtubule stabilizer and has been shown to lead to the phosphorlation of Bcl-2, thereby activating/amplifying the intrinsic apoptotic pathway. Reports by Cao et al. 37 have shown that treatment of PBcl-2 cells with docetaxel reduces Bcl-2 expression having a cytotoxic effect at clinical doses and sensitizes these cells to irradiation. In the current study, minimal cytotoxic effect of docetaxel treatment was found in any of the cell types examined due to the subclinical dosage utilized; however, a similar combinatorial effect of Freezing/Tax treatment was still observed in all conditions. In regards to TRAIL treatment, studies by Rokhlin et al. 26 have shown that the Bcl-2 upregulation in PBcl-2 protects the cells from TRAILmediated apoptosis. These observations were confirmed in the TRAIL alone condition; however, the Freeze/TRAIL combination appeared to overcome the protective effect maintaining enhanced cell destruction. Although both the Tax or TRAIL and Freezing combinations were found to yield enhanced cell death over either of the treatments alone, only the Freeze/TRAIL combination resulted in near-complete cell death in all cell variants examined. These data suggest that hybrid (rapid and delayed) apoptotic induction maybe a common phenomenon in prostate cancer and that the dual path recruitment/activation approach (freeze/TRAIL) may provide for a more effective route for cell destruction than that of mono-pathway amplification strategies such as freezing and docetaxel.
During cryosurgery, the edge of the targeted tissue is often target for freezing to a temperature at p À 40 1C due to the incomplete cell death in the freeze zone periphery at elevated temperatures. The overfreezing, referred to as a 'positive freeze margin' while beneficial to help assure more complete cancer ablation, it is often associated with undesirable damage to nontargeted tissue structures such as neurovascular bundles. Given concerns with potential cancer cell survival linked to reoccurrence, as well as limiting damage to nontargeted structures, recent efforts have shifted towards identifying adjuvants that can act synergistically with freezing to render the entire frozen area completely lethal. The results of the current study suggest that if the upstream activation of caspase-8 (extrinsic apoptosis) can be induced by cryoablation, then more effective outcomes maybe achieved. Further, by more closely simulating actual in vivo conditions, the tissue-engineered 3D prostate model supports more accurate predictions of cell behavior in response to cryosurgery as well as other tumor ablative techniques.
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